AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC
AUAUniversity12 Heinä 2019

AUA2019 048IC Novel Agents & Concepts In The Management Of Hormone Naïve & CRPC

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: https://auau.auanet.org/content/novel-agents-concepts-management-hormone-na%C3%AFve-castrate-resistant-prostate-cancer-webcast-0 This course will include short didactic lectures followed by case presentations to give attendees an understanding of the many new FDA-approved agents, as well as existing standard therapies, for advanced prostate cancer-both non-metastatic and metastatic CRPC. Particular attention will be devoted to sequencing the new agents and positioning them as compared to older existing therapies. The cost effectiveness of new and existing agents will also be addressed. Learning Objectives: Diagnose both non-metastatic and metastatic castrate resistant prostate cancer (nmCRPC, mCRPC) and have a working knowledge of treatments and the proper order for administration. Manage nm and mCRPC with systemic agents by learning the proper candidates for treatment and be able to counsel patients on the pros and cons of therapy. Analyze the mechanism of action and risks/benefits of using systemic agents in the treatment of nm/mCRPC. Describe the bone-targeted, radiopharmaceutical agent and its sequencing. Review the newer generation antiandrogen agents and their use in nmCRPC and in mCRPC.

Jaksot(421)

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

The goal of the course is to provide both a basic and real-world application of immunotherapy for genitourinary oncology. The course is directed towards the urologist with an interest, but no prior ex...

1 Elo 20181h 55min

AUA2018 063IC - Prostate Cancer Update

AUA2018 063IC - Prostate Cancer Update

This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2017 to April 2018. Focus will be placed on artic...

29 Heinä 20181h 59min

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as wel...

25 Heinä 20181h 54min

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether bi...

11 Heinä 20182h 1min

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

5 Heinä 201831min

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active...

23 Kesä 20182h 12min

Focal Therapy Interview with John W. Davis, MD, FACS

Focal Therapy Interview with John W. Davis, MD, FACS

Dr. Nitti and Dr. Davis discus the use of focal therapy in the treatment of prostate cancer. @jdhdavis - This file has been updated

15 Kesä 201833min

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

Highlights in Renal Cell Carcinoma: The Evolving Landscape of Adjuvant Therapy (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

8 Kesä 201842min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
rss-narsisti
adhd-podi
rss-liian-kuuma-peruna
rss-duodecim-lehti
jari-sarasvuo-podcast
psykologia
rss-koira-haudattuna
rahapuhetta
leveli
rss-uskonto-on-tylsaa
rss-valo-minussa-2
rss-luonnollinen-synnytys-podcast
rss-niinku-asia-on
kesken
salainen-paivakirja
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-tietoinen-yhteys-podcast-2